Compare Sezzle Inc (SEZL) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sezzle Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Sezzle Inc trades at $179.07 (market cap $5.78B), while State Street SPDR S&P Biotech ETF trades at $154.49. Which is the better fit depends on your goals.
| SEZL | XBI | |
|---|---|---|
Market Cap | $5.78B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $188.55 | $164.28 |
52-Week Low | $50.97 | $85.16 |
Enterprise Value | $5.80B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
